title: Chemokine receptor CXCR3 desensitization by IL-16/CD4 signaling is dependent on CCR5 and intact membrane cholesterol.
abstract: Previous work has shown that IL-16/CD4 induces desensitization of both CCR5- and CXCR4-induced migration, with no apparent effect on CCR2b or CCR3. To investigate the functional relationship between CD4 and other chemokine receptors, we determined the effects of IL-16 interaction with CD4 on CXCR3-induced migration. In this study we demonstrate that IL-16/CD4 induced receptor desensitization of CXCR3 on primary human T cells. IL-16/CD4 stimulation does not result in surface modulation of CXCR3 or changes in CXCL10 binding affinity. This effect does require p56(lck) enzymatic activity and the presence of CCR5, because desensitization is not transmitted in the absence of CCR5. Treatment of human T cells with methyl-beta-cyclodextrin, a cholesterol chelator, prevented the desensitization of CXCR3 via IL-16/CD4, which was restored after reloading of cholesterol, indicating a requirement for intact cholesterol. These studies demonstrate an intimate functional relationship among CD4, CCR5, and CXCR3, in which CCR5 can act as an adaptor molecule for CD4 signaling. This process of regulating Th1 cell chemoattraction may represent a mechanism for orchestrating cell recruitment in Th1-mediated diseases.
authors.affiliation: Pulmonary Center, Boston University School of Medicine, Boston, MA 02118, USA.
authors.forename: Shilpa
authors.initials: S
authors.lastname: Rahangdale
authors.forename: Roger
authors.initials: R
authors.lastname: Morgan
authors.forename: Claudia
authors.initials: C
authors.lastname: Heijens
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Ryan
authors.forename: Hisato
authors.initials: H
authors.lastname: Yamasaki
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Bentley
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Sullivan
authors.forename: David M
authors.initials: DM
authors.lastname: Center
authors.forename: William W
authors.initials: WW
authors.lastname: Cruikshank
mesh_terms: D000818:Animals; D015704:CD4 Antigens / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000378:metabolism*; D002462:Cell Membrane / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D002465:Cell Movement; D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism*; D005786:Gene Expression Regulation; D006801:Humans; D019410:Interleukin-16 / Q000494:pharmacology*; D019860:Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D011485:Protein Binding; D019713:Receptors, CCR5 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D054367:Receptors, CXCR3; D019707:Receptors, Chemokine / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D015704:CD4 Antigens; C515187:CXCR3 protein, human; C515188:Cxcr3 protein, mouse; D019410:Interleukin-16; D019713:Receptors, CCR5; D054367:Receptors, CXCR3; D019707:Receptors, Chemokine; D002784:Cholesterol; D019860:Lymphocyte Specific Protein Tyrosine Kinase p56(lck)